A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease

医学 透析 血液透析 内科学 逻辑回归 终末期肾病 弗雷明翰风险评分 肾脏疾病 体质指数 疾病 外科
作者
Cécile Couchoud,M Labeeuw,Olivier Moranne,Vincent Allot,Vincent Esnault,Luc Frimat,Bénédicte Stengel
出处
期刊:Nephrology Dialysis Transplantation [Oxford University Press]
卷期号:24 (5): 1553-1561 被引量:302
标识
DOI:10.1093/ndt/gfn698
摘要

The aim of this study was to develop and validate a prognostic score for 6-month mortality in elderly patients starting dialysis for end-stage renal disease.Using data from the French Rein registry, we developed a prognostic score in a training sample of 2500 patients aged 75 years or older who started dialysis between 2002 and 2006, which we validated in a similar sample of 1642 patients. Multivariate logistic regression with 500 bootstrap samples allowed us to select risk factors from 19 demographic and baseline clinical variables.The overall 6-month mortality was 19%. Age was not associated with early mortality. Nine risk factors were selected and points assigned for the score were as follows: body mass index <18.5 kg/m2 (2 points), diabetes (1), congestive heart failure stages III to IV (2), peripheral vascular disease stages III to IV (2), dysrhythmia (1), active malignancy (1), severe behavioural disorder (2), total dependency for transfers (3) and unplanned dialysis (2). The median score was 2. Mortality rates ranged from 8% in the lowest risk group (0 point) to 70% in the highest risk group (> or =9 points) and 17% in the median group (2 points). Seventeen percent of all deaths occurred after withdrawal from dialysis, ranging from 0% for a score of 0-1 to 15% for a score of 7 or higher.This simple clinical score effectively predicts short-term prognosis among elderly patients starting dialysis. It should help to illuminate clinical decision making, but cannot be used to withhold dialysis. It ought to only be used by nephrologists to facilitate the discussion with the patients and their families.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
happy发布了新的文献求助10
1秒前
1秒前
2秒前
abe发布了新的文献求助10
3秒前
天天开心完成签到 ,获得积分10
3秒前
4秒前
5秒前
6秒前
所所应助clean采纳,获得10
7秒前
sad完成签到,获得积分10
8秒前
学术地瓜发布了新的文献求助10
8秒前
9秒前
10秒前
爱静静应助跳跃的访烟采纳,获得10
10秒前
在水一方应助圣晟胜采纳,获得10
11秒前
12秒前
12秒前
12秒前
segama完成签到 ,获得积分10
12秒前
在人中完成签到,获得积分10
12秒前
顾矜应助tangyuyi采纳,获得10
12秒前
我是老大应助满意冷荷采纳,获得10
15秒前
凝子老师发布了新的文献求助10
15秒前
Qinpy发布了新的文献求助20
16秒前
跳跃的访烟完成签到,获得积分10
16秒前
bkagyin应助janice采纳,获得10
17秒前
17秒前
clean发布了新的文献求助10
17秒前
会飞的木头应助Anquan采纳,获得10
19秒前
炫哥IRIS完成签到,获得积分10
19秒前
21秒前
思源应助凝子老师采纳,获得10
22秒前
hhx完成签到,获得积分10
24秒前
在水一方应助圣晟胜采纳,获得10
26秒前
希格斯玻色子完成签到,获得积分10
26秒前
29秒前
在人中发布了新的文献求助10
31秒前
小蘑菇应助学术地瓜采纳,获得10
31秒前
33秒前
苏苏发布了新的文献求助10
34秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3528020
求助须知:如何正确求助?哪些是违规求助? 3108260
关于积分的说明 9288139
捐赠科研通 2805889
什么是DOI,文献DOI怎么找? 1540202
邀请新用户注册赠送积分活动 716950
科研通“疑难数据库(出版商)”最低求助积分说明 709849